These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3504501)

  • 1. A new approach to encapsulating nonsteroidal anti-inflammatory drugs. I. Bioavailability and gastric ulcerogenic activity.
    Meshali MM; el-Dien EZ; Omar SA; Luzzi LA
    J Microencapsul; 1987; 4(2):133-40. PubMed ID: 3504501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of encapsulation of mefenamic acid with cationic Eudragit E on its bioavailability and gastric ulcerogenic activity in rabbits.
    Ramadan EM; el-Helw A; el-Said Y
    J Microencapsul; 1987; 4(2):125-32. PubMed ID: 3504500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new approach to encapsulating nonsteroidal anti-inflammatory drugs. II. Physiochemical properties.
    Meshali MM; el-Dien EZ; Omar SA; Luzzi LA
    J Microencapsul; 1987; 4(2):141-50. PubMed ID: 3504502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new approach to encapsulating nonsteroidal anti-inflammatory drugs. IV. Effect of cellulose derivatives with different functional groups on the bioavailability and gastric ulcerogenic activity of acidic as well as basic nonsteroidal anti-inflammatory drugs.
    Meshali MM; el-Dien EZ; Omar SA; Luzzi LA
    J Microencapsul; 1989; 6(3):355-60. PubMed ID: 2569511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of particle size and film thickness on bioavailability and ulcerogenicity of encapsulated flufenamic acid.
    Foda A el-M ; el Said Y
    J Microencapsul; 1989; 6(2):227-32. PubMed ID: 2723967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
    Fiorucci S; Santucci L; Distrutti E
    Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissolution, bioavailability and ulcerogenic studies on piroxicam-nicotinamide solid dispersion formulations.
    Verma MM; Kumar MT; Balasubramaniam J; Pandit JK
    Boll Chim Farm; 2003 Apr; 142(3):119-24. PubMed ID: 12806831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats.
    Schmassmann A; Peskar BM; Stettler C; Netzer P; Stroff T; Flogerzi B; Halter F
    Br J Pharmacol; 1998 Mar; 123(5):795-804. PubMed ID: 9535006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The mechanism of the ulcerogenic action of nonsteroidal anti-inflammatory preparations].
    Bondarev AI; Zarudiĭ FS
    Eksp Klin Farmakol; 1994; 57(1):66-73. PubMed ID: 8142871
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
    Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
    J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gastric mucosa changes caused by anti-inflammatory agents in childhood].
    Berni Canani M; Cirillo B; Della Rotonda GM; Berni Canani R
    Pediatr Med Chir; 1996; 18(4):377-81. PubMed ID: 9064669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new approach to encapsulating non-steroidal anti-inflammatory drugs. V. Biopharmaceutical study of microcapsules of azapropazone coated with pectin and rutin.
    Meshali MM; el-Dien EZ; Omar SA; Luzzi LA
    J Microencapsul; 1992; 9(1):67-72. PubMed ID: 1613645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
    Yeomans ND
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S89-92. PubMed ID: 10379475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSAID-induced gastric mucosal damage.
    Semble EL; Wu WC
    Am Fam Physician; 1987 Jun; 35(6):101-8. PubMed ID: 3332745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preferential COX-2 inhibition: its clinical relevance for gastrointestinal non-steroidal anti-inflammatory rheumatic drug toxicity].
    Dammann HG
    Z Gastroenterol; 1999 Jan; 37(1):45-58. PubMed ID: 10091284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric mucosal injury by nonsteroidal anti-inflammatory drugs is reduced by (R)-alpha-methylhistamine and its pro-drugs in the rat.
    Morini G; Grandi D; Krause M; Schunack W
    Inflamm Res; 1997 Mar; 46 Suppl 1():S101-2. PubMed ID: 9098786
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of nonsteroidal anti-inflammatory drugs on endogenous gastrointestinal prostaglandins and therapeutic strategies for prevention and treatment of nonsteroidal anti-inflammatory drug-induced damage.
    Cryer B; Feldman M
    Arch Intern Med; 1992 Jun; 152(6):1145-55. PubMed ID: 1599341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of non-steroidal anti-inflammatory drugs on the stomach].
    Svintsitskiĭ AS
    Klin Med (Mosk); 1990 Sep; 68(9):18-22. PubMed ID: 2290318
    [No Abstract]   [Full Text] [Related]  

  • 19. Variations in the risk of gastrointestinal hemorrhage with non-steroidal anti-inflammatory drugs and localization of lesions.
    Pulanić R; Dubravcić D; Ostojić-Pulanić B; Vrhovac B
    Acta Med Croatica; 1998; 52(2):91-8. PubMed ID: 9682495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of some nonsteroidal anti-inflammatory drugs on experimental induced gastric ulcers in rats.
    Batu OS; Erol K
    Inflammopharmacology; 2007 Dec; 15(6):260-5. PubMed ID: 18236017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.